Clinical safety of inhaled corticosteroids for asthma in children: An update of long-term trials

Drug Safety

Volumn 29, Issue 7, 2006, Pages 599-612

  Pedersen, Søren ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b KOLDING HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID DERIVATIVE; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; GLUCOCORTICOID; HYDROCORTISONE; NEDOCROMIL; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SALBUTAMOL; SALMETEROL; THEOPHYLLINE;

ADRENAL INSUFFICIENCY; ALLERGIC RHINITIS; ASTHMA; BODY HEIGHT; BONE DENSITY; BONE DISEASE; BONE GROWTH; CLINICAL PRACTICE; CLINICAL STUDY; CLINICAL TRIAL; CUSHINGOID SYNDROME; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; FRACTURE; GROWTH RATE; HUMAN; HYPOGLYCEMIA; INCIDENCE; LONG TERM CARE; MEDICAL LITERATURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; BODY HEIGHT; BONE DENSITY; CHILD; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; HUMANS; HYDROCORTISONE;

EID: 33746796224     PISSN: 01145916     EISSN: 01145916     Source Type: Journal    
DOI: 10.2165/00002018-200629070-00005     Document Type: Review

References (71)

1. Skoner DP. Balancing safety and efficacy in pediatric asthma management. Pediatrics 2002; 109: 381-92
2. O'Riordan TG. Optimizing delivery of inhaled corticosteroids: matching drugs with devices. J Aerosol Med 2002; 15: 245-50
3. Eid NS. Update on National Asthma Education and Prevention Program pediatric asthma treatment recommendations. Clin Pediatr (Phila) 2004; 43: 793-802
4. Pocket guide for asthma management and prevention in children [online]. Available from URL: http://www.ginasthma.com/[Accessed 2005 Jul 21]
5. British guideline on the management of asthma [online]. Available from URL: www.sign.ac.uk/pdf/sign63.pdf [Accessed 2005 Jul 21]
6. Vermeire PA, Rabe KF, Soriano JB, et al. Asthma control and differences in management practices across seven European countries. Respir Med 2002; 96: 142-9
7. Rabe KF, Adachi M, Lai CK, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004; 114: 40-7
8. van Grunsven PM. The magnitude of fear of adverse effects as a reason for nonparticipation in drug treatment: a short review. J Asthma 2001; 38: 113-9
9. Data on file. GlaxoSmithKline. 2004
10. Data on file. AstraZeneca. 2004
11. Pedersen S. Do inhaled corticosteroids inhibit growth in children? Am J Respir Crit Care Med 2001; 164: 521-35
12. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000; 343: 1064-9
13. Merkus PJ, van Essen-Zandvliet EE, Duiverman EJ, et al. Long-term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Pediatrics 1993; 91: 1121-6
14. Roux C, Kolta S, Desfougeres JL, et al. Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma. Pediatrics 2003; 111: e706-13
15. Allen DB, Bronsky EA, LaForce CF, et al. Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group. J Pediatr 1998; 132: 472-7
16. Price JF, Russell G, Hindmarsh PC, et al. Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma. Pediatr Pulmonol 1997; 24: 178-86
17. Bisgaard H, Allen D, Milanowski J, et al. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics 2004; 113: e87-94
18. Jonasson G, Carlsen KH, Jonasson C, et al. Low-dose inhaled budesonide once or twice daily for 27 months in children with mild asthma. Allergy 2000; 55: 740-8
19. Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343: 1054-63
20. Verberne AA, Frost C, Roorda RJ, et al. One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. Am J Respir Crit Care Med 1997; 156: 688-95
21. Tinkelman DG, Reed CE, Nelson HS, et al. Aerosol beclometasone compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993; 92: 64-77
22. Simons FE. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med 1997; 337: 1659-65
23. Skoner DP, Szefler SJ, Welch M, et al. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma. J Allergy Clin Immunol 2000; 105: 259-68
24. Irani AM, Cruz-Rivera M, Fitzpatrick S, et al. Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma. Ann Allergy Asthma Immunol 2002; 88: 306-12.
25. Scott MB, Skoner DP. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma. J Allergy Clin Immunol 1999; 104: 200-9
26. Visser MJ, van der Veer E, Postma DS, et al. Side-effects of fluticasone in asthmatic children: no effects after dose reduction. Eur Respir J 2004; 24: 420-5
27. Visser MJ, Postma DS, Arends LR, et al. One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height. Am J Respir Crit Care Med 2001; 164: 2073-7
28. de Benedictis FM, Teper A, Green RJ, et al. Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial. Arch Pediatr Adolesc Med 2001; 155: 1248-54
29. Rao R, Gregson RK, Jones AC, et al. Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone. Eur Respir J 1999; 13: 87-94
30. Allen DB. Systemic effects of inhaled corticosteroids in children. Curr Opin Pediatr 2004; 16: 440-4
31. Price J, Hindmarsh P, Hughes S, et al. Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature? Eur Respir J 2002; 19: 1179-93
32. Larsson L, Gerhardsson de Verdier M, Lindmark B, et al. Budesonide-treated asthmatic adolescents attain target height: a population-based follow-up study from Sweden. Pharmacoepidemiol Drug Saf 2002; 11: 715-20
33. Inoue T, Doi S, Takamatsu I, et al. Effect of long-term treatment with inhaled beclometasone on growth of asthmatic children. J Asthma 1999; 36: 159-64
34. Silverstein MD, Yunginger JW, Reed CE, et al. Attained adult height after childhood asthma: effect of glucocorticoid therapy. J Allergy Clin Immunol 1997; 99: 466-74
35. Van Bever HP, Desager KN, Lijssens N, et al. Does treatment of asthmatic children with inhaled corticosteroids affect their adult height? Pediatr Pulmonol 1999; 27: 369-75
36. Norjavaara E, Gerhardsson De Verdier M, Lindmark B. Reduced height in Swedish men with asthma at the age of conscription for military service. J Pediatr 2000; 137: 25-9
37. Allen DB, Mullen M, Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 1994; 93: 967-76
38. Jones A, Fay JK, Burr M, et al. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002; (1): CD003537
39. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312: 1254-9
40. Allen DB. Limitations of short-term studies in predicting long-term adverse effects of inhaled corticosteroids. Allergy 1999; 54 Suppl. 49: 29-34
41. Kelly HW, Strunk RC, Donithan M, et al. Growth and bone density in children with mild-moderate asthma: a cross-sectional study in children entering the Childhood Asthma Management Program (CAMP). J Pediatr 2003; 142: 286-91
42. Gregson RK, Rao R, Murrills AJ, et al. Effect of inhaled corticosteroids on bone mineral density in childhood asthma: comparison of fluticasone propionate with beclomethasone dipropionate. Osteoporosis Int 1998; 8 (5): 418-22
43. Schlienger RG, Jick SS, Meier CR. Inhaled corticosteroids and the risk of fractures in children and adolescents. Pediatrics 2004; 114: 469-73
44. van Staa TP, Bishop N, Leufkens HG, et al. Are inhaled corticosteroids associated with an increased risk of fracture in children? Osteoporos Int 2004; 15: 785-91
45. van Staa TP, Cooper C, Leufkens HG, et al. Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res 2003; 18: 913-8
46. Pedersen S, O'Byrne PM, Busse WW, et al. Fracture rate in patients with asthma receiving long-term early intervention with budesonide: the START study [abstract]. Annual meeting of the European Respiratory Society (ERS). Suplementum from the ERS meeting; 2005 Sep 17-21; Copenhagen, 1855
47. Harris M, Hauser S, Nguyen TV, et al. Bone mineral density in prepubertal asthmatics receiving corticosteroid treatment. J Paediatr Child Health 2001; 37: 67-71
48. Jones G, Ponsonby AL, Smith BJ, et al. Asthma, inhaled corticosteroid use, and bone mass in prepubertal children. J Asthma 2000; 37: 603-11
49. Agertoft L, Pedersen S. Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide. Am J Respir Crit Care Med 1998; 157: 178-83
50. Allen HD, Thong IG, Clifton-Bligh P, et al. Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma. Pediatr Pulmonol 2000; 29: 188-93
51. Hansen OR, Nokkentved K. Adverse effects in children treated with ACTH in infantile spasm [in Danish]. Ugeskr Laeger 1989; 151: 2194-5
52. Winzenberg T, Shaw K, Fryer J, et al. Calcium supplementation for improving bone mineral density in children. Cochrane Database Syst Rev 2006; (2): CD005119
53. Leflein JG, Szefler SJ, Murphy KR, et al. Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial. Pediatrics 2002; 109: 866-72
54. Skoner DP, Szefler SJ, Welch M, et al. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma. J Allergy Clin Immunol 2000; 105: 259-68
55. Bacharier LB, Raissy HH, Wilson L, et al. Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma. Pediatrics 2004; 113: 1693-9
56. Verona E, Petrov D, Cserhati E, et al. Fluticasone propionate in asthma: a long term dose comparison study. Arch Dis Child 2003; 88: 503-9
57. Donnelly R, Williams KM, Baker AB, et al. Effects of budesonide and fluticasone on 24-hour plasma cortisol: a dose-response study. Am J Respir Crit Care Med 1997; 156: 1746-51
58. Grahnen A, Jansson B, Brundin RM, et al. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler. Eur J Clin Pharmacol 1997; 52: 261-7
59. Dahl R, Lundback B, Malo JL, et al. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group. Chest 1993; 104: 1352-8
60. Bisgaard H, Damkjaer Nielsen M, Andersen B, et al. Adrenal function in children with bronchial asthma treated with beclometasone or budesonide. J Allergy Clin Immunol 1988; 81: 1088-95
61. Martin RJ, Szefler SJ, Chinchilli VM, et al. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med 2002; 165: 1377-83
62. Todd GR, Acerini CL, Ross-Russell R, et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002; 87: 457-61
63. DIN-LINK data. Compufile Ltd. 2003 Oct
64. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999; 159: 941-55
65. Allen DB. Safety of inhaled corticosteroids in children. Pediatr Pulmonol 2002; 33: 208-20
66. Argenti D, Jensen B, Vaccaro S. Pharmacokinetic evaluation of single doses of oral and inhaled triamcinolone acetonide with or without administration of oral charcoal. Asthma Theory to Treatment. Abstract book from the joint AAAAI and ATS; 1995, Chicago
67. Holliday SM, Faulds D, Sorkin EM. Inhaled fluticasone propionate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma. Drugs 1994; 47: 318-31
68. Pavord I, Knox A. Pharmacokinetic optimisation of inhaled steroid therapy in asthma. Clin Pharmacokinet 1993; 25: 126-35
69. Ryrfeldt A, Andersson P, Edsbacker S, et al. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis Suppl 1982; 122: 86-95
70. Agertoft L, Larsen FE, Pedersen S. Posterior subcapsular cataracts, bruises and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide. Eur Respir J 1998; 12: 130-5
71. Silverman M, Sheffer AL, Diaz PV, et al. Safety and tolerability of inhaled budesonide in children in the steroid treatment as regular therapy in early asthma (START) trial. Pediatr Allergy Immunol 2006; 17 Suppl. 17: 14-20